Key result
Higher monocyte to HDL cholesterol ratio was an independent predictor of high intracoronary thrombus burden in patients with STEMI undergoing primary PCI.
Why the study?
Does the monocyte to HDL cholesterol ratio predict high intracoronary thrombus burden in patients with STEMI undergoing primary PCI?
Observational (n=414)
Does the monocyte to HDL cholesterol ratio predict high intracoronary thrombus burden in patients with STEMI undergoing primary PCI?
The monocyte to HDL cholesterol ratio is an independent predictor of high angiographic thrombus burden in STEMI patients undergoing primary PCI, potentially aiding in risk stratification.
Answers are grounded in this paper and cite their sources.
MHR may identify STEMI patients at higher thrombus risk during PCI; hypothesis-generating and should not yet change practice.
Intracoronary thrombus burden is associated with some adverse events and poor prognosis in patients with ST-segment elevation myocardial infarction (STEMI). Identifying predictors of the intracoronary thrombus burden may contribute to the management of STEMI. In this study, we evaluated whether monocyte count to high-density lipoprotein cholesterol ratio (MHR) is a predictor of intracoronary thrombus burden in patients with STEMI. The study population consisted of 414 patients with STEMI who underwent primary percutaneous coronary intervention (PCI). Angiographic thrombus burden was classified based on thrombolysis in myocardial infarction (TIMI) thrombus grades. The patients were grouped into 2 categories of low thrombus burden and high thrombus burden. The MHR was significantly higher in the high thrombus burden group compared with the low thrombus group (16.0 [9.2-22.1] vs 25.4 [13.5-44.6]; P < .001). In multivariate logistic regression analysis, MHR was an independent predictor of high thrombus burden (odds ratio: 1.067, 95% CI: 1.031-1.105; P < .001). The area under the receiver-operating characteristic curve of the MHR was 0.688 (0.641-0.733; P < .001) to predict high thrombus burden. In conclusion, MHR was independent predictor of high thrombus burden in patients with STEMI who underwent primary PCI.
No takes yet. Share an insight, caveat, or question.
Arısoy et al. (2016) conducted an observational in ST-segment elevation myocardial infarction (STEMI) (n=414). Monocyte to HDL cholesterol ratio (MHR) was evaluated on High intracoronary thrombus burden (OR 1.067, 95% CI 1.031-1.105, p=< .001). Higher monocyte to HDL cholesterol ratio was an independent predictor of high intracoronary thrombus burden in patients with STEMI undergoing primary PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: